News Conference News EuroPCR 2024 Solid 2-Year Data With ‘Unlocking’ Coronary Stent: BIOADAPTOR RCT Michael O'Riordan May 28, 2024
News Conference News EuroPCR 2024 Stepwise DAPT De-escalation Shows Promise in DCB-Only PCI for ACS Yael L. Maxwell May 15, 2024
News Daily News Agent Coronary DCB Gets FDA Approval for In-Stent Restenosis L.A. McKeown March 01, 2024
News Daily News Long-term Data Support Paclitaxel-Coated Balloons for In-Stent Restenosis Michael O'Riordan February 24, 2023
News Conference News EuroPCR 2022 Long-term Outcomes With PCI and CABG: More Analyses to Stir the Pot Michael O'Riordan May 23, 2022
News Conference News TCT 2019 IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease Michael O'Riordan September 26, 2019
News Conference News ESC 2018 BASKET-SMALL 2: Drug-Coated Balloon Fares Well Against DES for De Novo Small-Vessel Disease Todd Neale August 28, 2018
News Conference News CRT 2018 Time to Shine: ‘Historic’ All-Female Team Takes Over Live Case at CRT 2018 Michael O'Riordan March 06, 2018
News Conference News TCT 2016 ‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent Michael O'Riordan October 30, 2016
News Daily News Residual Dissection After DCB Treatment for De Novo CAD Generally Resolves Caitlin E. Cox November 26, 2015
News Daily News DCB Matches DES in Treating ‘Real-World’ Patients With In-Stent Restenosis March 04, 2015
News Conference News EuroPCR 2013 EuroPCR 2013: From Cutting-Edge Devices to the Clinical Challenges Caitlin E. Cox May 29, 2013
News Daily News Angioplasty May Be Alternative to Surgery for Common Femoral Artery Disease Jason Kahn August 08, 2011
News Conference News PRECOMBAT: PCI with Sirolimus Stent Equivalent to CABG in Left Main Disease April 05, 2011